abbvieacquiresacquisitionacquisitionsactivityadvancementsadvancesaheadaiamidapprovalsarrowheadastrazenecabigbillionbiobiogenbiontechbiopharmabiotechnologybreakingbreakthroughbreakthroughsbuzzcancercareceochallengeschinesecomplexitiescourtdatadealdelaydevelopmentdevelopmentsdosedropdrugelevidyseliessentialeverevolvingexpansionfdafinancialgenegskhealthcarehearingshivimpactindustryinformedinnovationinnovationsinsightsinvestmentjrkeepingkeylandscapelatestleaderslillylossmarketmattersmerckmergersmilestonesmodernamorningmovesmrnanavigatingnewsnordisknovartisnovoobesityoctoberoncologyopportunitiespartnershipspfizerpharmaceuticalspolicyprecisionproductionpromisingquickregeneronregulatoryrejectionsreviewrevolutionizingrfkrisernarocherulingsareptasenatesetbackshiftssoarsstaystockstoriesstrategicstrategiesstudysuccesssupremesurgetarifftherapeuticstherapiestherapytimestoptransformativetransparencytrendstrumpturbulentuncertaintyupdateupdatesvaccinevaccinesweekweightworld